1.
Senkpeil L, Bhardwaj J, Little MR, et al. Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccine. JCI insight. 2024. doi:10.1172/jci.insight.167408.
1.
Woo HG, Kim HJ, Park J, et al. Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database. Journal of medical virology. 2024;96(4):e29591. doi:10.1002/jmv.29591.
1.
Lee K, Lee H, Kwon R, et al. Global burden of vaccine-associated anaphylaxis and their related vaccines, 1967-2023: A comprehensive analysis of the international pharmacovigilance database. Allergy. 2023. doi:10.1111/all.15968.
1.
McNamara RP, Maron JS, Boucau J, et al. Anamnestic humoral correlates of immunity across SARS-CoV-2 variants of concern. mBio. 2023:e0090223. doi:10.1128/mbio.00902-23.
1.
Borriello F, van Haren SD, Levy O. First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines. mSphere. 2018;3(4). doi:10.1128/mSphere.00214-18.
1.
Haining N, Pulendran B. Identifying gnostic predictors of the vaccine response. Curr Opin Immunol. 2012;24(3):332-6. doi:10.1016/j.coi.2012.03.010.
1.
Netea MG, Joosten LAB, Latz E, et al. Trained immunity: A program of innate immune memory in health and disease. Science. 2016;352(6284):aaf1098. doi:10.1126/science.aaf1098.
1.
Pardee K, Slomovic S, Nguyen PQ, et al. Portable, On-Demand Biomolecular Manufacturing. Cell. 2016;167(1):248-259.e12. doi:10.1016/j.cell.2016.09.013.